Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Recurrent cancer
ADR ID BADD_A07636
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.16      Miscellaneous and site unspecified neoplasms malignant and unspecified
16.16.01      Neoplasms malignant site unspecified NEC
16.16.01.015      Recurrent cancer
Description Not Available
MedDRA Code 10038111
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Reactivation of carcinoma | Recurrent cancer
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00047Afatinib0.000224%
BADD_D00142Anastrozole0.000159%
BADD_D00151Apixaban0.000130%
BADD_D00194Azacitidine0.000112%
BADD_D00318Busulfan0.000224%
BADD_D00349Capecitabine0.000492%
BADD_D00364Carboplatin0.000168%
BADD_D00566Dabrafenib0.000112%
BADD_D00589Dasatinib0.000168%
BADD_D00800Erlotinib0.000302%
BADD_D00858Everolimus0.000535%
BADD_D00931Fluorouracil--
BADD_D01136Imatinib0.002239%
BADD_D01248Lapatinib0.000112%
BADD_D01257Letrozole0.000790%
BADD_D01549Nelarabine0.000112%
BADD_D01601Olaparib0.000616%
BADD_D01687Pazopanib0.000414%
BADD_D01835Pregabalin0.000052%
BADD_D02105Tacrolimus0.000297%
BADD_D02111Tamoxifen0.000238%
BADD_D02150Temozolomide0.000728%
BADD_D02345Venetoclax0.000112%
BADD_D02365Vismodegib--
BADD_D02392Zoledronic acid--
BADD_D02412Octreotide0.000466%
BADD_D02434Cinacalcet0.000391%
BADD_D02464Fingolimod0.000651%
BADD_D02480Alectinib0.000112%
BADD_D02483Ribociclib0.000168%
The 1th Page    1 2    Next   Last    Total 2 Pages